Superoxide dismutase gene polymorphisms in patients with age-related cataract

Ophthalmic Genetics

Volumn 34, Issue 3, 2013, Pages 140-145

  Celojevic, Dragana ^a   Nilsson, Staffan ^b   Behndig, Anders ^c   Tasa, Gunnar ^d   Juronen, Erkki ^d   Karlsson, Jan Olof ^a   Zetterberg, Henrik ^a,e   Petersen, Anne ^a   Zetterberg, Madeleine ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY OF TARTU   (Estonia)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cataract; Oxidative stress; Single nucleotide polymorphisms; SOD genes

Indexed keywords

SUPEROXIDE DISMUTASE;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENILE CATARACT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; AGING; CATARACT; FEMALE; GENE FREQUENCY; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SUPEROXIDE DISMUTASE;

EID: 84880361056     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810.2012.746377     Document Type: Article

References (47)

1. Davies KJ. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 2000;50:279-289.
2. Hodge WG, Whitcher JP, Satariano W. Risk factors for agerelated cataracts. Epidemiol Rev 1995;17:336-346.
3. Spector A, Garner WH. Hydrogen peroxide and human cataract. Experiment Eye Res 1981;33:673-681.
4. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001;119:1439-1452.
5. Chylack Jr. LT, Brown NP, Bron A, et al. The Roche European American Cataract Trial (REACT): A randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of agerelated cataract. Ophthalmic Epidemiol 2002;9:49-80.
6. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001;389:84-93.
7. HapMap-Consortium. The International HapMap Project. Nature 2003;426:789-796.
8. Barrett JC, Fry B, Maller J, et al. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
9. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296: 2225-2229.
10. Livak KJ. Allelic discrimination using fluorogenic probes and the 50 nuclease assay. Genet Anal 1999;14:143-149.
11. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 1977;106:17-32.
12. Klein BE, Klein R, Linton KL. Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology 1992;99:546-552.
13. Kelly SP, Thornton J, Edwards R, et al. Smoking and cataract: Review of causal association. J Cataract Refract Surg 2005;31:2395-2404.
14. Cumming RG, Mitchell P. Hormone replacement therapy, reproductive factors, and cataract. The Blue Mountains Eye Study. Am J Epidemiol 1997;145:242-249.
15. Altman DG. Practical statistics for medical research. London, New York: Chapman and Hall; 1991.
16. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Human Genet 2005;76:887-893.
17. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995;12:921-927.
18. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biologic Chem 1969;244:6049-6055.
19. Weisiger RA, Fridovich I. Mitochondrial superoxide dimutase. Site of synthesis and intramitochondrial localization. J Biologic Chem 1973;248:4793-4796.
20. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Nat Acad Sci USA 1982;79:7634-7638.
21. Behndig A, Svensson B, Marklund SL, et al. Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci 1998;39:471-475.
22. Rajkumar S, Praveen MR, Gajjar D, et al. Activity of superoxide dismutase isoenzymes in lens epithelial cells derived from different types of age-related cataract. J Cataract Refract Surg 2008;34:470-474.
23. Taylor HR,West SK, Rosenthal FS, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 1988; 319:1429-1433.
24. Wang J, Lofgren S, Dong X, et al. Evolution of light scattering and redox balance in the rat lens after in vivo exposure to close-to-threshold dose ultraviolet radiation. Acta Ophthalmol 2010;88:779-785.
25. Lin D, Barnett M, Grauer L, et al. Expression of superoxide dismutase in whole lens prevents cataract formation. Molec Vision 2005;11:853-858.
26. Matsui H, Lin LR, Ho YS, et al. The effect of up- and downregulation of MnSOD enzyme on oxidative stress in human lens epithelial cells. Invest Ophthalmol Visual Sci 2003;44:3467-3475.
27. Olofsson EM, Marklund SL, Behndig A. Enhanced agerelated cataract in copperzinc superoxide dismutase null mice. Clin Experiment Ophthalmol 2012;40:813-820.
28. Zhang Y, Zhang L, Sun D, et al. Genetic polymorphisms of superoxide dismutases, catalase, and glutathione peroxidase in age-related cataract. Molec Vision 2011;17: 2325-2332.
29. Huret JL, Delabar JM, Marlhens F, et al. Down syndrome with duplication of a region of chromosome 21 containing the CuZn superoxide dismutase gene without detectable karyotypic abnormality. Hum Genet 1987;75:251-257.
30. Krawczak M, Cooper DN. The human gene mutation database. Trends Genet 1997;13:121-122.
31. Pagano G, Castello G. Oxidative stress and mitochondrial dysfunction in Down syndrome. Adv Experiment Med Biol 2012;724:291-299.
32. Kowald A, Klipp E. Alternative pathways might mediate toxicity of high concentrations of superoxide dismutase. Ann NY Acad Sci 2004;1019:370-374.
33. Creavin AL, Brown RD. Ophthalmic abnormalities in children with Down syndrome. J Pediatr Ophthalmol Strabismus 2009;46:76-82.
34. Al-Kateb H, Boright AP, Mirea L, et al. Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study. Diabetes 2008;57:218-228.
35. Mohammedi K, Maimaitiming S, Emery N, et al. Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. Mol Genet Metab 2011; 104:654-660.
36. Panduru NM, Cimponeriu D, Cruce M, et al. Association of 35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes. Rom J Morphol Embryol 2010;51:37-41.
37. Hendrickson DJ, Fisher JH, Jones C, et al. Regional localization of human extracellular superoxide dismutase gene to 4pter-q21. Genomics 1990;8:736-738.
38. Sandstrom J, Nilsson P, Karlsson K, et al. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biologic Chem 1994;269:19163-19166.
39. Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proc Nat Acad Sci USA 1996;93:4471-4473.
40. Church SL, Grant JW, Meese EU, et al. Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping. Genomics 1992;14:823-825.
41. Hiroi S, Harada H, Nishi H, et al. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Bioph Res Co 1999;261:332-339.
42. Wang LI, Miller DP, Sai Y, et al. Manganese superoxide dismutase alanine-tovaline polymorphism at codon 16 and lung cancer risk. J Nat Cancer Institute 2001;93:1818-1821.
43. Wiener HW, Perry RT, Chen Z, et al. A polymorphism in SOD2 is associated with development of Alzheimer's disease. Genes Brain Behav 2007;6:770-775.
44. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, et al. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Bioph Res Co 1996;226:561-565.
45. Ergen HA, Narter F, Timirci O, et al. Effects of manganese superoxide dismutase Ala-9Val polymorphism on prostate cancer: A case-control study. Anticancer Res 2007; 27:1227-1230.
46. Ambrosone CB, Freudenheim JL, Thompson PA, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999;59:602-606.
47. Soerensen M, Christensen K, Stevnsner T, et al. The Mnsuperoxide dismutase single nucleotide polymorphism rs4880 and the glutathione peroxidase 1 single nucleotide polymorphism rs1050450 are associated with aging and longevity in the oldest old. Mech Ageing Dev 2009;130: 308-314.